Asked by: James Wild (Conservative - North West Norfolk)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment has been made of the gap between NHS England’s 2018 commissioning target of 1,000 LAAO procedures per annum and current delivery.
Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)
I refer the Hon. Member to the answer provided on 24 June in response to Question 10430.
Asked by: James Wild (Conservative - North West Norfolk)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many and what proportion of inspections of NHS hospitals by the Care Quality Commission were (a) announced and (b) unannounced in each of the last three years.
Answered by Diana Johnson - Minister of State (Department of Health and Social Care)
Under the Care Quality Commission’s (CQC’s) current assessment methodology, not every assessment of a National Health Service hospital involves a site visit.
The following table provides the number and proportion of announced and unannounced NHS hospital site visits, rather than assessments, recorded by the CQC in 2024, 2025 and 2026 to date:
Year | Announced site visits | Unannounced site visits | Total site visits | Additional assessment activities with no site visit recorded |
2024 | 68 (74%) | 24 (26%) | 92 | 6 |
2025 | 186 (72%) | 71 (28%) | 257 | 134 |
2026 | 114 (49%) | 119 (51%) | 233 | 214 |
Total | 368 (63%) | 214 (37%) | 582 | 354 |
Asked by: James Wild (Conservative - North West Norfolk)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what percentage increase in dental training places is planned for each year of this Parliament.
Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)
I refer the Hon Member to the answer provided on 18 March in response to Question 117934.
Asked by: James Wild (Conservative - North West Norfolk)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps her Department is taking to ensure that funding decisions for brain tumour research reflect the prevalence and clinical impact of low-grade glioma.
Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)
Some of the data requested by the Hon. Member is not centrally held, but on the wider issues raised, I refer him to the answer provided on 3 March in response to Question 115098. Available data on this issue is also published by the National Institute for Health and Care Research at the following link:
https://www.nihr.ac.uk/our-research/cancer/brain-tumours
Asked by: James Wild (Conservative - North West Norfolk)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether her Department plans to increase investment in research relating to low-grade glioma over the next spending period.
Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)
Some of the data requested by the Hon. Member is not centrally held, but on the wider issues raised, I refer him to the answer provided on 3 March in response to Question 115098. Available data on this issue is also published by the National Institute for Health and Care Research at the following link:
https://www.nihr.ac.uk/our-research/cancer/brain-tumours
Asked by: James Wild (Conservative - North West Norfolk)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what funding her Department has allocated to research into low-grade glioma in each of the last five years.
Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)
Some of the data requested by the Hon. Member is not centrally held, but on the wider issues raised, I refer him to the answer provided on 3 March in response to Question 115098. Available data on this issue is also published by the National Institute for Health and Care Research at the following link:
https://www.nihr.ac.uk/our-research/cancer/brain-tumours
Asked by: James Wild (Conservative - North West Norfolk)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, when she plans to respond to the Hughes Report on valporate and pelvic mesh.
Answered by Diana Johnson - Minister of State (Department of Health and Social Care)
I refer the Hon Member to the answer provided on 14 July in response to Question 16121.
Asked by: James Wild (Conservative - North West Norfolk)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment she has made of the availability of specialist treatment services for patients diagnosed with low-grade glioma across England.
Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)
I refer the Hon Member to the answer provided to the Hon Member for Chingford and Woodford Green on 26 May 2026 in response to Question 1100.
Asked by: James Wild (Conservative - North West Norfolk)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what estimate she has made of the annual NHS expenditure on the treatment and management of low-grade glioma patients in England.
Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)
I refer the Hon Member to the answer provided to the Hon Member for Chingford and Woodford Green on 26 May 2026 in response to Question 1100.
Asked by: James Wild (Conservative - North West Norfolk)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to support research to identify a cure for Creutzfeldt-Jakob disease.
Answered by Preet Kaur Gill
The Department commissions research through the National Institute for Health and Care Research (NIHR) and invests over £1.8 billion a year on applied health and care research. The NIHR welcomes funding applications for research into any aspect of human health including Creutzfeldt-Jakob disease (CJD) and clinical trials for therapeutics. Applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money, and scientific quality.
Since 2002, the NIHR has made available over £43 million of funding for research to address key evidence gaps on variant CJD including the development of a treatment for variant CJD, a diagnostic test for sub-clinical variant CJD, and decontamination of surgical instruments.
Recognising the devasting impact of CJD on patients and their loved ones as well as the current lack of a treatment, Department officials met with the Director of the Medical Research Council’s Prion Unit in October 2024 to discuss possible clinical trials for a candidate therapeutic, namely prion protein monoclonal antibody therapy, for CJD. The researchers were advised to explore the NIHR Efficacy and Mechanism Evaluation programme as a route of funding.